Florida · Claims for harm from Allergan implants

Claims for harm from Allergan implants in Florida

See If You Qualify

Free · No obligation · About 2 minutes

Filing deadline4 years from discovery for product liability claims (§§ 95.11(3)(d), 95.031(2)(b)); 2 years for negligence claims (§ 95.11(5)(a))§ 95.11(3)(d)

Deadlines vary with the facts of each case. A lawyer can confirm yours.

Updated

01 · Your filing deadline

What is the deadline in Florida?

Florida: 4 years for product-injury actions (§ 95.11(3)(d)) A lawyer can confirm yours.

4 years from discovery for product liability claims (§§ 95.11(3)(d), 95.031(2)(b)); 2 years for negligence claims (§ 95.11(5)(a))

Source: § 95.11(3)(d)

Deadlines vary; a lawyer can confirm yours. An older diagnosis or a past filing window does not, by itself, establish whether you have a claim.

Woman on the phone on her sofa, smiling
A lawyer can check which filing rules apply to your circumstances.

02 · Where cases are heard

Where would my case be heard?

Florida is a Tier 1 priority state for Allergan BIOCELL claims. Miami and Fort Lauderdale rank among the top cosmetic surgery markets nationally. Florida has a 2-year statute of limitations from discovery, with a potential 4-year window under product liability provisions. AbbVie reported that in June 2026 it agreed to resolve substantially all U.S. BIA-ALCL lawsuits; an attorney can say whether that agreement or MDL 2921 applies to a particular claim.

Florida plaintiffs may join MDL 2921 (D.N.J., Judge Brian R. Martinotti) or file in Florida state court. Florida state court does not have a coordinated BIOCELL proceeding as of early 2026. Federal filings in Florida originate in the Southern District of Florida (Miami Division) or Middle District of Florida (Tampa or Orlando Divisions) before JPML transfer to New Jersey. Florida is among the top three states by plaintiff volume in MDL 2921.

Florida's statute of limitations for personal injury is four years under Fla. Stat. § 95.11(3)(a), one of the longest in the country and favorable for BIOCELL plaintiffs with delayed diagnoses. Florida also recognizes the delayed-discovery rule for latent disease: the limitations period runs from when the plaintiff knew or should have known of the injury. For BIA-ALCL, this is generally the diagnosis date. Note that Florida amended its products liability statute in 2023 (HB 837); plaintiffs should confirm applicable limitation periods based on their implant and diagnosis dates.

Key Florida venues include Miami-Dade Circuit Court (Complex Business Litigation Section), Broward County Circuit Court (Fort Lauderdale), Palm Beach County Circuit Court, and Hillsborough County Circuit Court (Tampa). In federal court, Southern District of Florida Judge Cecilia Altonaga (Miami) and Middle District of Florida judges in Tampa regularly handle complex product liability matters prior to MDL transfer. Florida applies the Daubert standard for expert testimony under § 90.702, amended in 2013.

Florida's BIOCELL exposure is heavily concentrated in South Florida (Miami-Dade, Broward, Palm Beach counties), Tampa Bay, and Orlando. South Florida's large cosmetic surgery market — driven by plastic surgery practice density in Miami Beach, Boca Raton, and Fort Lauderdale — resulted in high BIOCELL implant placement rates. Florida also has a significant international patient population for cosmetic procedures, which can create service-of-process and jurisdiction considerations for certain defendants.

How this works nationally

For the overall process and updates, read the Claims for harm from Allergan implants overview. This page covers the local information available for Florida.

What happens when I check?

You answer a few short questions about what happened. If you send them, your answers are kept on file. If a participating law firm takes these cases, it may contact you. People's Justice is not a law firm.

Live in Florida? Read what applies in your state.

Register your interest. If a participating law firm takes these cases, it may contact you.

Register your interest

Sources

  1. § 95.11(3)(d)